Our prize lectures always form the spine of the scientific programme of our annual meeting, and that’s no different for Pharmacology 2018. These lectures are deserved recognition for the winners of…
An impressive line-up of industry experts have agreed to join a new high-level Scientific Advisory Panel to help drive the British Pharmacological Society’s scientific and research dissemination…
The Research Excellence Framework (REF) is the system for assessing the quality of research in UK higher education institutions. The REF was first carried out in 2014, replacing the…
Cardiovascular calcification is a major health concern in patients with kidney failure undergoing haemodialysis. A first-time-in-human clinical trial of an investigational calcification inhibitor has…
The Society responded to the "Developing the long-term plan for the NHS" consultation from NHS England, jointly as the Clinical Pharmacology Skills Alliance (CPSA). The Society…
Randomised clinical trials are by far the best tool we have to assess whether a medicine works or not. Governments and regulators demand to see the results of the highest quality trials to make…
Infection with human papillomavirus (HPV) can cause certain cancers in women and men, but HPV vaccines are highly effective in preventing infection with oncogenic HPV types. A new British Journal of…
The idea of a magic bullet is very compelling and attractive. Curing diseases with the precise delivery of therapeutics to the target cell or microorganism has received the attention of many…
Up until the late 70s, pharmacological discovery was a process exemplified by increasing technical expertise in surgery and bioassay, and was associated with a series of important discoveries.…
Bee venom and its major component, melittin, may be effective treatments for atopic dermatitis (or eczema), according to a British Journal of Pharmacology study. Through studies conducted in mice…
